Cytosorbents Corp

MONMOUTH JUNCTION, NJ · Medtech · Public

Blood purification device for removing pathogenic substances from patient blood in critical care settings

Claim this profile

Follows are private to you and power your alerts

Updated · cytosorbents.com

Sector
Medtech
Headquarters
MONMOUTH JUNCTION, NJ
Latest Form D
$745K, Oct 2013
Total capital
$5.1M
Federal grants
$3.3M
5 awards · 2018–2023
5.0× sector median 1 award
Private capital raised
$1.8M
2 Form D · last Oct 2013
157 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

201320152017201920212023FEDERAL ↑EQUITY ↓Cumulative $5.1M$996K$983K$992K$282K$7K2nd Form D$745K
201320152017201920212023FEDERAL ↑EQUITY ↓Cumulative $5.1M$996K$983K$992K$282K1st Form D$1.1M

Latest events

  • Federal grantHealth and Human S · Phase I · Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability$7K
  • Federal grantHealth and Human S · Phase I · Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability$282K
  • Federal grantHealth and Human S · Phase II · pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads$992K
  • Federal grantHealth and Human S · Phase II · pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads$983K
  • Federal grantHealth and Human S · Phase II · pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads$996K
  • Private capital raisedForm D · SEC · 2nd filing$745K
  • Private capital raisedForm D · SEC · 1st filing$1.1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Founders and team

Researcher links verified by same-company patents and grants
  • Phillip ChanResearcherExecutive Officer, DirectorLinked by $3.3M in grants as PI
  • Al P. KrausDirectorNamed in SEC Form D filings
  • Dr. Phillip P ChanExecutive Officer, DirectorNamed in SEC Form D filings
  • Edward R. JonesDirectorNamed in SEC Form D filings
  • James R. GuntonDirectorNamed in SEC Form D filings
  • Joseph P RubinDirectorNamed in SEC Form D filings
Show all 8 people
  • Kathleen P. BlochExecutive OfficerNamed in SEC Form D filings
  • Vincent P. CapponiExecutive OfficerNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

  • Fresenius Medical Care South Lewisville, LLCSimilar federal contract value in Medtech · null in contracts
  • Tenex Health, Inc.Similar federal contract value in Medtech · null in contracts
  • OssiFi IncSimilar federal contract value in Medtech · null in contracts
  • Diagnos Inc.Similar federal contract value in Medtech · null in contracts
  • Osteologix, Inc.Similar federal contract value in Medtech · null in contracts
  • DigiPath,Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .